SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys more than $1.3 billion, three-year agreement to supply engines, license propulsion technology and provide engineering support to AST SpaceMobile is driving attention and a sharp share-price jump. Many traders view the deal as validation of Fireflys engine business and a major backlog boost, while others question the payment terms, potential dilution and whether the rally can hold ahead of earnings.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs sharp rebound after a steep photonics-sector selloff is being discussed alongside Foxconn Tech Day evidence of POET optical hardware in Foxconns ecosystem, which bulls view as validation of its AI data-center opportunity. Skeptics note that a product display or design relationship does not confirm purchase orders, scaled shipments, or revenue, and are looking to upcoming results for proof of commercialization.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Baker Bros reported purchase of roughly 247,000 Kodiak shares is driving attention, with bullish traders treating the major holders buying as a vote of confidence and a challenge to short sellers. Others remain skeptical, citing KODs high valuation and potential financing needs; traders are also watching for upcoming pipeline data.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors Duchenne muscular dystrophy therapy deramiocel, with traders weighing HOPE-3 upper-limb data and a letter from treating specialists against concerns about the FDA review and the risk of a rejection. The debate is fueling bullish approval expectations and speculative talk of a short squeeze, alongside warnings that the outcome remains uncertain.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gileads quarterly results beat expectations and the company raised its full-year product-sales outlook, with traders pointing to strength in its HIV franchise and growing prevention-drug demand. The reaction is broadly positive, though some remain cautious about acquisition-related accounting costs and put-heavy options activity.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos Q3 update and agreement to reserve U.S. Forged Rings manufacturing capacity for future reactor components are driving a sharp rebound, alongside attention to its cash position and nuclear-development progress. Bulls see supply-chain progress and demand for nuclear power as reasons for optimism, while skeptics point to limited revenue, high valuation, and dilution and insider-selling concerns.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

A stronger-than-expected quarterly report and Googles credit support for financing tied to TeraWulfs Anthropic data-center lease have fueled optimism, with a new construction agreement adding to the buildout narrative. Bulls see the developments as reducing financing risk, while skeptics cite losses, debt, execution risks and weakness across AI data-center stocks; the reaction has been volatile.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,011,579 in circulation. The last known price of Autonomi is 0.02922544 USD and is up 6.14 over the last 24 hours. It is currently trading on 15 active market(s) with $124,611.31 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Discussion is dominated by ticker confusion: many posts use ANT.X for Anthropics proposed IPO, debating its valuation and large AI-compute commitments, rather than Aragons crypto token. Aragon-specific posts are fragmented across its completed token-redemption/dissolution and DAO-governance updates, with no clear current catalyst established.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JDs rebound above its 200-day average, alongside unusually call-heavy options activity, has traders debating whether the move has further momentum or will fade. Earnings expectations are adding interest, though some traders remain cautious about a sell-the-news reaction and the stocks volatile trading history.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Speculation around the federal cannabis Schedule III process, including the ALJ recommendation and potential 280E tax relief, is the dominant topic. Bullish traders point to Green Thumbs balance sheet, buybacks and recent results, while others question its margins and lagging share performance and remain wary of regulatory delays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

VOTE VOTE

Latest VOTE News